Samer Al Hadidi, Associate Professor at UAMS – University of Arkansas for Medical Sciences, shared on X, about a recent paper by Bhavesh Mohan Lal et al. published in Blood Advances:
“Check our recent work Blood Advances, UAMS Myeloma Center led by Bhavesh Mohan Lal.
Prior exposure resulted in lower PFS and OS especially for pts who previously responded to Belantamab with no dependency on time of use
Important when considering sequencing in future.”
Authors: Bhavesh Mohan Lal et al.
Bhavesh Mohan Lal, Junior Resident at AIIMS (All India Institute of Medical Sciences, New Delhi), shared this post on X, adding:
“Thank you very much for this opportunity and for your guidance, Dr Al Hadidi”